Form 4 Tracker
Kevin J Buchi

Director · 3 filings · Latest: Aug 11, 2026

Amneal Pharmaceuticals, Inc.
Benitec Biopharma Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AMRX
Kevin J BuchiDirectorAug 11, 2026
Option Exercise
$17.18168,573$2.9M93,499
AMRX
BUCHI J KEVINAug 11, 2026
Proposed Sale
$17.31168,573$2.9M
AMRX
Kevin J BuchiDirectorMay 7, 2026
Option Exercise
34,81975,077